Japan Diabetes Care Devices Market Outlook to 2016
Publisher Name » GlobalData
Published Date » 2010-04-30
No. Of Pages » 72
GlobalDatas medical equipment report offering, Japan Diabetes Care Devices Market Outlook to 2016 provides key market data on the Japan diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Market size and company share data for two diabetes care devices market categories Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Japan diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Japan diabetes care devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contents
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.1 What Is This Report About? 9
3 Diabetes Care Devices In Japan 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Japan, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Japan, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Japan, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Japan, Company Share (2008-2009) 20
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Japan, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Japan, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Japan, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Japan, Company Share (2008-2009) 20
4 Glucose Monitoring In Japan 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Japan, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Japan, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.5 Glucose Monitoring Overall Volume (2002-2016) 27
4.6 Glucose Monitoring Average Price (2002-2016) 29
4.7 Glucose Monitoring Distribution Share (2008-2009) 30
4.8 Glucose Monitoring, Japan, Company Share (2008-2009) 31
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Japan, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Japan, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.5 Glucose Monitoring Overall Volume (2002-2016) 27
4.6 Glucose Monitoring Average Price (2002-2016) 29
4.7 Glucose Monitoring Distribution Share (2008-2009) 30
4.8 Glucose Monitoring, Japan, Company Share (2008-2009) 31
5 Insulin Delivery In Japan 33
5.1 Insulin Delivery, Market Segmentation 33
5.2 Insulin Delivery Market, Japan, Revenue Mix ($m), 2009 34
5.3 Insulin Delivery Market, Japan, Category Contribution (%), 2009 35
5.4 Insulin Delivery Overall Revenue (2002-2016) 36
5.4.1 Insulin Pens Revenue (2002-2016) 40
5.5 Insulin Delivery Overall Volume (2002-2016) 42
5.5.1 Insulin Pens Volume (2002-2016) 46
5.6 Insulin Delivery Average Price (2002-2016) 48
5.7 Insulin Delivery Distribution Share (2008-2009) 49
5.8 Insulin Delivery, Japan, Company Share (2008-2009) 50
5.1 Insulin Delivery, Market Segmentation 33
5.2 Insulin Delivery Market, Japan, Revenue Mix ($m), 2009 34
5.3 Insulin Delivery Market, Japan, Category Contribution (%), 2009 35
5.4 Insulin Delivery Overall Revenue (2002-2016) 36
5.4.1 Insulin Pens Revenue (2002-2016) 40
5.5 Insulin Delivery Overall Volume (2002-2016) 42
5.5.1 Insulin Pens Volume (2002-2016) 46
5.6 Insulin Delivery Average Price (2002-2016) 48
5.7 Insulin Delivery Distribution Share (2008-2009) 49
5.8 Insulin Delivery, Japan, Company Share (2008-2009) 50
6 Overview of Key Companies in Japan Diabetes Care Devices Market 52
6.1 ARKRAY, Inc. 52
6.1.1 Company Overview 52
6.1.2 Share in the Japan Diabetes Care Devices Market 52
6.2 F. Hoffmann-La Roche Ltd. 53
6.2.1 Company Overview 53
6.2.2 Share in the Japan Diabetes Care Devices Market 53
6.3 LifeScan, Inc. 54
6.3.1 Company Overview 54
6.3.2 Share in the Japan Diabetes Care Devices Market 54
6.4 Novo Nordisk A/S 55
6.4.1 Company Overview 55
6.4.2 Share in the Japan Diabetes Care Devices Market 55
6.5 Eli Lilly and Company 56
6.5.1 Company Overview 56
6.5.2 Share in the Japan Diabetes Care Devices Market 56
6.6 Sanofi-Aventis 57
6.6.1 Company Overview 57
6.6.2 Share in the Japan Diabetes Care Devices Market 57
6.7 Abbott Laboratories 58
6.7.1 Company Overview 58
6.7.2 Share in the Japan Diabetes Care Devices Market 58
6.8 Becton, Dickinson and Company 59
6.8.1 Company Overview 59
6.9 B. Braun Melsungen AG 59
6.9.1 Company Overview 59
6.10 Medtronic, Inc. 59
6.10.1 Company Overview 59
6.11 Terumo Corporation 60
6.11.1 Company Overview 60
6.12 Smiths Medical 60
6.12.1 Company Overview 60
6.13 Hindustan Syringes & Medical Devices Ltd. 61
6.13.1 Company Overview 61
6.14 Bayer HealthCare AG 61
6.14.1 Company Overview 61
6.15 Apex Biotechnology Corp. 62
6.15.1 Company Overview 62
6.16 Animas Corporation 62
6.16.1 Company Overview 62
6.17 Fuso Pharmaceutical Industries, Ltd. 62
6.17.1 Company Overview 62
6.1 ARKRAY, Inc. 52
6.1.1 Company Overview 52
6.1.2 Share in the Japan Diabetes Care Devices Market 52
6.2 F. Hoffmann-La Roche Ltd. 53
6.2.1 Company Overview 53
6.2.2 Share in the Japan Diabetes Care Devices Market 53
6.3 LifeScan, Inc. 54
6.3.1 Company Overview 54
6.3.2 Share in the Japan Diabetes Care Devices Market 54
6.4 Novo Nordisk A/S 55
6.4.1 Company Overview 55
6.4.2 Share in the Japan Diabetes Care Devices Market 55
6.5 Eli Lilly and Company 56
6.5.1 Company Overview 56
6.5.2 Share in the Japan Diabetes Care Devices Market 56
6.6 Sanofi-Aventis 57
6.6.1 Company Overview 57
6.6.2 Share in the Japan Diabetes Care Devices Market 57
6.7 Abbott Laboratories 58
6.7.1 Company Overview 58
6.7.2 Share in the Japan Diabetes Care Devices Market 58
6.8 Becton, Dickinson and Company 59
6.8.1 Company Overview 59
6.9 B. Braun Melsungen AG 59
6.9.1 Company Overview 59
6.10 Medtronic, Inc. 59
6.10.1 Company Overview 59
6.11 Terumo Corporation 60
6.11.1 Company Overview 60
6.12 Smiths Medical 60
6.12.1 Company Overview 60
6.13 Hindustan Syringes & Medical Devices Ltd. 61
6.13.1 Company Overview 61
6.14 Bayer HealthCare AG 61
6.14.1 Company Overview 61
6.15 Apex Biotechnology Corp. 62
6.15.1 Company Overview 62
6.16 Animas Corporation 62
6.16.1 Company Overview 62
6.17 Fuso Pharmaceutical Industries, Ltd. 62
6.17.1 Company Overview 62
7 Diabetes Care Devices Market Pipeline Products 63
8 Appendix 66
8.1 Definitions of Markets Covered in the Report 67
8.1.1 Diabetes Care Devices 67
8.2 Research Methodology 69
8.3 Secondary Research 70
8.4 Primary Research 70
8.5 Models 71
8.6 Forecasts 71
8.7 Expert Panels 71
8.8 Currency Conversion 72
8.9 Contact Us 72
8.10 Disclaimer 72
8.1 Definitions of Markets Covered in the Report 67
8.1.1 Diabetes Care Devices 67
8.2 Research Methodology 69
8.3 Secondary Research 70
8.4 Primary Research 70
8.5 Models 71
8.6 Forecasts 71
8.7 Expert Panels 71
8.8 Currency Conversion 72
8.9 Contact Us 72
8.10 Disclaimer 72
List of Tables
Table 1: Diabetes Care Devices, Japan, Overall Revenue ($m), 2002-2016 11
Table 2: Diabetes Care Devices Market, Japan, Category Contribution (%), 2009 13
Table 3: Diabetes Care Devices, Japan, Cross-Segment Analysis,2002-2016 14
Table 4: Diabetes Care Devices, Japan, Overall Revenue ($m), Historic, 2002-2009 15
Table 5: Diabetes Care Devices, Japan, Overall Revenue ($m), Forecast, 2009-2016 16
Table 6: Diabetes Care Devices, Japan, Category Volume (Units), 2002-2016 17
Table 7: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2002-2009 18
Table 8: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2009-2016 19
Table 9: Diabetes Care Devices, Japan, Company Share by Revenue ($m), 2008-2009 21
Table 10: Glucose Monitoring Market, Japan, Category Contribution (%), 2009 24
Table 11: Glucose Monitoring, Japan, Revenue ($m) by Segment, Historic, 2002-2009 25
Table 12: Glucose Monitoring, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 26
Table 13: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2002-2009 27
Table 14: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2009-2016 28
Table 15: Glucose Monitoring, Japan, Average Price ($), Historic, 2002-2009 29
Table 16: Glucose Monitoring, Japan, Average Price ($), Forecast, 2009-2016 29
Table 17: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), 2008-2009 30
Table 18: Glucose Monitoring, Japan, Company Share by Revenue ($m), 2008-2009 32
Table 19: Insulin Delivery Market, Japan, Category Contribution (%), 2009 35
Table 20: Insulin Delivery, Japan, Revenue ($m) by Segment, Historic, 2002-2009 37
Table 21: Insulin Delivery, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 39
Table 22: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 23: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Table 24: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2002-2009 43
Table 25: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2009-2016 45
Table 26: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2002-2009 46
Table 27: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 47
Table 28: Insulin Delivery, Japan, Average Price ($), Historic, 2002-2009 48
Table 29: Insulin Delivery, Japan, Average Price ($), Forecast, 2009-2016 48
Table 30: Insulin Delivery, Japan, Distribution Share by Revenue ($m), 2008-2009 49
Table 31: Insulin Delivery, Japan, Company Share by Revenue ($m), 2008-2009 51
Table 32: Diabetes Care Devices Pipeline Products 63
Table 33: USD to Local Currency, Japan, Average Actual Rate 2002-2009 72
List of Figures
List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Japan, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, Japan, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, Japan, Cross-Segment Analysis,2002-2016 14
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, Japan, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, Japan, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, Japan, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, Japan, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, Japan, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2002-2009 27
Figure 18: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, Japan, Company Share (%), 2009 31
Figure 20: Insulin Delivery, Market Segmentation 33
Figure 21: Insulin Delivery Market, Japan, Revenue Mix ($m), 2009 34
Figure 22: Insulin Delivery Market, Japan, Category Contribution (%), 2009 35
Figure 23: Insulin Delivery, Japan, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 24: Insulin Delivery, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 38
Figure 25: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Figure 26: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 27: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2002-2009 42
Figure 28: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2009-2016 44
Figure 29: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2002-2009 46
Figure 30: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 47
Figure 31: Insulin Delivery, Japan, Company Share (%), 2009 50
Figure 32: ARKRAY, Inc., Company Share (%), Japan Diabetes Care Devices Market, 2009 52
Figure 33: F. Hoffmann-La Roche Ltd, Company Share (%), Japan Diabetes Care Devices Market, 2009 53
Figure 34: LifeScan, Inc., Company Share (%), Japan Diabetes Care Devices Market, 2009 54
Figure 35: Novo Nordisk A/, Company Share (%), Japan Diabetes Care Devices Market, 2009 55
Figure 36: Eli Lilly and Company, Company Share (%), Japan Diabetes Care Devices Market, 2009 56
Figure 37: Sanofi-Aventis, Company Share (%), Japan Diabetes Care Devices Market, 2009 57
Figure 38: Abbott Laboratories, Company Share (%), Japan Diabetes Care Devices Market, 2009 58
Figure 39: GlobalData Methodology 69
Figure 2: Diabetes Care Devices, Japan, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, Japan, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, Japan, Cross-Segment Analysis,2002-2016 14
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, Japan, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, Japan, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, Japan, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, Japan, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, Japan, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2002-2009 27
Figure 18: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, Japan, Company Share (%), 2009 31
Figure 20: Insulin Delivery, Market Segmentation 33
Figure 21: Insulin Delivery Market, Japan, Revenue Mix ($m), 2009 34
Figure 22: Insulin Delivery Market, Japan, Category Contribution (%), 2009 35
Figure 23: Insulin Delivery, Japan, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 24: Insulin Delivery, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 38
Figure 25: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Figure 26: Insulin Pens, Japan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 27: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2002-2009 42
Figure 28: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2009-2016 44
Figure 29: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2002-2009 46
Figure 30: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 47
Figure 31: Insulin Delivery, Japan, Company Share (%), 2009 50
Figure 32: ARKRAY, Inc., Company Share (%), Japan Diabetes Care Devices Market, 2009 52
Figure 33: F. Hoffmann-La Roche Ltd, Company Share (%), Japan Diabetes Care Devices Market, 2009 53
Figure 34: LifeScan, Inc., Company Share (%), Japan Diabetes Care Devices Market, 2009 54
Figure 35: Novo Nordisk A/, Company Share (%), Japan Diabetes Care Devices Market, 2009 55
Figure 36: Eli Lilly and Company, Company Share (%), Japan Diabetes Care Devices Market, 2009 56
Figure 37: Sanofi-Aventis, Company Share (%), Japan Diabetes Care Devices Market, 2009 57
Figure 38: Abbott Laboratories, Company Share (%), Japan Diabetes Care Devices Market, 2009 58
Figure 39: GlobalData Methodology 69
Upcoming Reports:
|
Small Appliances Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Small appliances market is forecasted to grow substantially in all market segments through 2016 owing to the rise in living standards and need for more comfort. Small appliance industry consists of home appliances that are movable or partially movable and can be used on tables, counters, or other platforms. The growth of small appliances market is expected to be driven by product innovation, upgradation of existing products, and value-added features in the coming years. Small appliances are generally categorized as commercial and home appliances. Commercial appliances are meant...
|
|
Food Preservatives Market - Global And China Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Worldwide market for food preservatives is expected to grow at the compounded annual growth rate of 2.5% in next five years and reach the market value of $2.55 billion. This growth is mainly driven by increasing demand for natural food preservatives in developed markets and continued demand for processed food in emerging markets. The growing trend of using natural preservatives originated with the need for European countries to market clean label food products that are free from additives. Changing lifestyle and flourishing food and beverage industry are giving boost to...
|
|
Marine-Derived Pharmaceuticals Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018
By - Transparency Market Research
Description
Marine derived pharmaceuticals are the drugs and other pharmacological substances which are made from extracting elements present in marine life. Although the concept of marine ethnomedicine dates back to the 18th and 19th century, actual exploratory work on marine pharmacology began in the mid and late 1960s when groups of chemists in the United States, Japan, and Europe began to explore sponges, marine algae, and other forms of marine life for their medicinal properties.
At present there are several marine-derived pharmaceuticals available in the...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 Asian countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
